Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.

TSX:WEED - Post by User

Canopy Growth Corp > A Comparison of Canopy Growth to Entourage Health

<< Previous

Bullboard Posts

Next >>

Comment by TheGrapeOneon Nov 28, 2022 2:28pm

124 Views

Post# 35134522

RE:A Comparison of Canopy Growth to Entourage Health

Nice pump lol but the difference is the future $4.54 is nothing compared to where this is going as the deals are done and inplace to expand in to the US market which will result in sales revenue over a Billion

Wrywisdom wrote: As of November 9th, Canopy Growth

-currently has approximately 2.4% of the Canada Cannabis Market

-Lost 231.9 million dollars for the most recent quarter of reportage

-Is losing $7.31 per share with 480 million shares outstanding

-Is presently selling for $4.54 per share

Entourage has 2% of the Canada Market with strong capitalization, boasts a tiny fraction of Canaopy Growth's loss with 307 million shares out(35% less than Canopy) is implementing a host of initiatives gaining positive traction and sells for .04 per share

Anyone who considers the capital markets a rational barometer for company valuation entertains a totally irrational proposition...and this of course, is how the money is made and lost.